rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anthony E. Altig

Director

Company insider

Files Form 4 as: Director, Assembly Biosciences; Director, TearLab; Director, Optimer Pharmaceuticals; Director, MultiCell Technologies; Sr. VP, Finance & CFO, Diversa.

Every Form 4 they filed

In numbers

Trades disclosed
88
Buys
3
Sells
4
Bought
$87K
Sold
$96K
Companies
5
Companies where not an officer
4
First trade
15 Feb 2006
Last trade
4 Jun 2026
Last filed
5 Jun 2026

Companies traded

Where they are an officer
DiversaOfficer · last 16 May 20070 buys · 4 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ASMB Assembly BiosciencesDirector · Biotechnology · last 4 Jun 20260 buys · 0 sells
TearLabDirector · last 9 Jul 20202 buys · 0 sells
Optimer PharmaceuticalsDirector · last 24 Oct 20131 buy · 0 sells
MultiCell TechnologiesDirector · last 1 Jun 20120 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 5 Jun 2026ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
4 Jun 2026filed 5 Jun 2026ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
5 Jun 2025filed 9 Jun 2025ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—3,500 at $0.00filing
29 May 2024filed 30 May 2024ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—2,750 at $0.00filing
25 May 2023filed 30 May 2023ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
25 May 2022filed 27 May 2022ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
20 May 2021filed 24 May 2021ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
9 Jul 2020filed 9 Jul 2020TearLaboption or derivativeSEC FORM 4 Code U$101K1,666 at $60.81filing
9 Jul 2020filed 9 Jul 2020TearLabSEC FORM 4 Code U$5308,833 at $0.06filing
11 Jun 2020filed 15 Jun 2020ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
10 Mar 2020filed 12 Mar 2020TearLaboption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
17 May 2019filed 17 May 2019ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
30 May 2018filed 1 Jun 2018ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
7 Feb 2018filed 9 Feb 2018TearLaboption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
1 Jun 2017filed 5 Jun 2017ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
24 Jun 2016filed 28 Jun 2016TearLaboption or derivativeSEC FORM 4 Code A—15,000 at $0.00filing
2 Jun 2016filed 3 Jun 2016ASMB Assembly Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
9 May 2016filed 11 May 2016TearLabSEC FORM 4 Bought—33,334filing
9 May 2016filed 11 May 2016TearLaboption or derivativeSEC FORM 4 Code P—16,667filing
18 Jun 2015filed 22 Jun 2015TearLaboption or derivativeSEC FORM 4 Code A—15,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed7

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.